A. Monterrosa-Castro, Universidad de Cartagena, Cartagena, Colombia; J. E. Blümel, Universidad de Chile, Santiago, Chile; K. Portela-Buelvas, Universidad de Cartagena, Cartagena, Colombia; E. Mezones-Holguin, Instituto Nacional de Salud, Lima, Perú; G. Barón, Universidad El Bosque, Bogotá, Colombia; A. Bencosme, Hospital Metropolitano, Santiago, República Dominicana; Z. Benítez, Hospital Central, IPS, Asunción, Paraguay; L. M. Bravo, Universidad de Guadalajara, Guadalajara, México; A. Calle, Universidad Central del Ecuador, Quito, Ecuador; P. Chedraui, Universidad Católica, Guayaquil, Ecuador; D. Flores, Universidad Diego Portales, Santiago, Chile; M. T. Espinoza, Caja de Salud de la Banca Privada, Cochabamba, Bolivia; G. Gómez, Universidad del Valle, Cali, Colombia; J. A. Hernández- Bueno, Atención Médica Integral para la Mujer, México, México; F. Laribezcoa, Universidad Nacional de Piura, Piura, Perú; S. Lima, Hospital Militar, Montevideo, Uruguay; Mabel Martino, Universidad Nacional de Rosario, Argentina; D. Mostajo, Unidad de Diagnóstico Médico, Santa Cruz, Bolivia; E. Ojeda, Universidad Andina del Cusco, Cusco, Perú; W. Onatra, Universidad Ciencias Aplicadas y Ambientales, Colombia; H. Sánchez, Hospital de SOLCA, Machala, Ecuador; D. Navarro, Instituto Nacional de Endocrinología, La Habana, Cuba; K. Tserotas, Universidad de Panamá, Ciudad de Panamá, Panamá; M. S. Vallejo, Universidad de Chile, Santiago, Chile; S. Witis, Hospital de Clínicas San Martín, Buenos Aires, Argentina; M. C. Zúñiga, Obra Social de Empleado Públicos, Mendoza, Argentina.
Conflicto de interés Los autores no reportan conflictos de interés. Solo los autores son responsables por el contenido y la escritura de este artículo.
Fuente de financiación Nil.
Referencias
1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053.
2. Wedisinghe L, Perera M. Diabetes and menopause. Maturitas 2009;63:200-203.
3. Liao S, Li J, Wei W, et al. Association between diabetes mellitus and breast cancer risk: a meta-analysis of the literature. Asian Pac J Cancer Prev 2011;12:1061-1065.
4. Roglic G. Diabetes in women: the global perspective. Int J Gynaecol Obstet 2009;104 (Suppl 1):S11-S13.
5. Meyer MR, Clegg DJ, Prossnitz ER, Barton M. Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors. Acta Physiol (Oxf) 2011;203:259-269.
6. Szmuilowicz ED, Stuenkel CA, Seely EW. Influence of menopause on diabetes and diabetes risk. Nat Rev Endocrinol 2009;5:553-558.
7. Kim C. Does menopause increase diabetes risk? Strategies for diabetes prevention in midlife women. Women’s Health (Lond Engl) 2012;8:155-167.
8. Khoo CL, Perera M. Diabetes and the menopause. J Br Menopause Soc 2005;11:6-11.
9. Progetto Menopausa Italia Study Group. General and medical factors associated with hormone replacement therapy among women attending menopause clinics in Italy. Menopause 2001;8:290-295.
10. National Center for Health Statistics. Healthy people 2010. Final review. http://www.
cdc.gov/nchs/data/hpdata2010/hp2010_final_ review.pdf. Accessed: 14/04/2013
11. World Medical Association. Declaration of Helsinki. JAMA 1997;277:925-926.
12. CEPAL-ECLAC. Statistical Yearbook for Latin America and the Caribbean 2010. Santiago, Chile: United Nations Publication, 2011.
13. Organización Panamericana de la Salud. Guías ALAD de Diagnóstico, Control y Tratamiento de Diabetes Mellitus. Tipo II. Washington, DC: OPS, 2008:9.
14. CEPAL. Panorama Social de América Latina. 2012. http www.eclac.org/publicaciones/xml/5/48455/Panorama. Social2012DocIRev.pdf. Accessed: 14/04/2013
15. Soules MR, Sherman S, Parrott E, et al. Executive Summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001;4:267-272.
16. Heinemman K, Ruebig A, Potthof P. The menopause rating scale (MRS): A methodological review. Qual Life Res 2004;2:45.
17. Aedo S, Porcile A, Irribarra C. Calidad de Vida Relacionada con el Climaterio en una Población Chilena de Mujeres Saludables. Rev Chil Obstet Ginecol 2006;71:402-409.
18. Chedraui P, Aguirre W, Hidalgo L, Fayad L. Assessing menopausal symptoms among healthy middle aged women with the Menopause Rating Scale. Maturitas 2007;57: 271-278.
19. Goldberg D, Bridges K, Duncan-Jones P, Grayson D. Detecting anxiety and depression in general medical settings. BMJ 1988;297:897-899.
20. Montón C, Pérez Echeverria MI, Campos R, et al. Escalas de Ansiedad y Depresión de Goldberg: Una Guía de Entrevista Eficaz ´para la Detección del Malestar Psíquico. Atención Primaria 1993;12:345-349.
21. International Diabetes Federation. Diabetes Atlas, 5 th edn. Brussels, 2012. Http://www.idf.org/diabetesatlas/5e/the-global burden. Accessed: 14/04/2013
22. Gruppo di studio Progetto Menopausa Italia. Risk factors for type II diabetes in women attending menopause clinics in Italy: a crosssectional study. Climacteric 2005;8:287-293.
23. Olaiz-Fernández G, Rojas R, Aguilar-Salinas CA, Rauda J, Villalpando S. Diabetes mellitus in Mexican adults: results from the 2000 National Health Survey. Salud Pública Méx 2007;49(Suppl 3): s331-S337.
24. Cheung BM, Li C. Diabetes and hypertension: is there a common metabolic pathway? Curr Atheroscler Rep 2012;14:160-166.
25. Scheen AJ. Diabetes mellitus in the elderly: insulin resistance and/or impaired insulin secretion? Diabetes Metab 2005;31(Spec No. 2):5S27-34.
26. Kesavadev JD, Short KR, Nair KS. Diabetes in old age: an emerging epidemic. J Assoc Physicians India 2003;5:1083-1094.
27. Seidell JC. Obesity, insulin resistance and diabetes – a worldwide epidemic. Br J Nutr 2000; 83(Suppl 1):S5-S8.
28. Kim C, Edelstein SL, Crandall JP, et al. Diabetes Prevention Program Research Group. Menopause and risk of diabetes in the Diabetes Prevention Program. Menopause 2011;18: 857-868.
29. Manson JE, Rimm EB, Colditz GA, et al. A prospective study of postmenopausal estrogen therapy and subsequent incidence of noninsulin- dependent diabetes mellitus. Ann Epidemiol 1992;2:665-673.
30. de Lauzon-Guillain B, Fournier A, Fabre A, et al. Menopausal hormone therapy and newonset diabetes in the French Etude Epidemiologique de Femmes de la Mutuelle Générale
de l’Education Nationale (E3N) cohort. Diabetologia 2009;52:2092-100.
31. Pentti K, Tuppurainen MT, Honkanen R, et al. Hormone therapy protects from diabetes: the Kuopio Osteoporosis Risk Factor And Prevention Study. Eur J Endocrinol 2009;160: 979-983.
32. Yoshihara R, Utsunomiya K, Gojo A, et al. Association of polymorphism of estrogen receptor-alpha gene with circulating levels of adiponectin in postmenopausal women with type II diabetes. J Atheroscler Thromb 2009;16:250-255.
33. Li S, Shin HJ, Ding EL, van Dam RM. Adiponectin levels and risk of type II diabetes: a systematic review and meta-analysis. JAMA 2009;302:179-188.
34. Organización Panamericana de la Salud. Guías ALAD de Diagnóstico, Control y Tratamiento de Diabetes Mellitus Tipo II. Washington, DC: OPS, 2008.
35. Gamboa JL, Garcia-Cazarin ML, Andrade FH. Chronic hypoxia increases insulinstimulated glucose uptake in mouse soleus muscle. Am J Physiol Regul Integr Comp Physiol 2011;300:R85-91.
36. Cullmann M, Hilding A, Östenson CG. Alcohol consumption and risk of pre-diabetes and type II diabetes development in a Swedish population. Diabet Med 2012;29:441-452.
37. Khalil N, Sutton-Tyrrell K, Strotmeyer ES, et al. Menopausal bone changes and incident fractures in diabetic women: a cohort study. Osteoporos Int 2011;22:1367-1376.
38. Dorman JS, Steenkiste AR, Foley TP, et al. Familial Autoimmune and Diabetes (FAD) Study. Menopause in type I diabetic women: is it premature? Diabetes 2001;50:1857-1862.
39. Schunk M, Reitmeir P, Schipf S, et al. Healthrelated quality of life in subjects with and without type II diabetes: pooled analysis of five population-based surveys in Germany. Diabet Med 2012;29:646-653.
